BOULDER, Colo.--(BUSINESS WIRE)-- Array BioPharma Inc. (NASDAQ: ARRY) today reported financial results for the fourth quarter and full year of fiscal 2010. Array reported revenue of $18.0 million for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback